Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of and risk factors for diabetic retinopathy: The Thessaloniki Eye Study.

Eye (London, England)·2026
Same author

Primary Open-Angle Glaucoma among Black and Latinx Populations: Exploring Racial Disparities in the United States.

Journal of racial and ethnic health disparities·2026
Same author

Trabeculectomy Remains Essential for Glaucoma Care.

Ophthalmology. Glaucoma·2026
Same author

Innovating global regulatory frameworks for generative AI in medical devices is an urgent priority.

NPJ digital medicine·2026
Same author

Multicenter Interspecialty Consensus on Experimental Oncology Drug-Related Ocular Adverse Event Reporting.

JAMA ophthalmology·2025
Same author

Applying Race and Ethnicity in Health Disparities Research.

International journal of environmental research and public health·2025
Same journal

Polymorphisms of Aldose Reductase (ALR2) Regulatory Gene are Risk Factors for Diabetic Retinopathy in Type-2 Diabetes Mellitus Patients in Bali, Indonesia.

The open ophthalmology journal·2018
Same journal

Maximising Refractive Outcomes with an Extended Depth of Focus IOL.

The open ophthalmology journal·2018
Same journal

Refractive Error among Male Primary School Students in Jazan, Saudi Arabia: Prevalence and Associated Factors.

The open ophthalmology journal·2018
Same journal

Outcomes of Wavefront-Optimized Laser-Assisted <i>In-Situ</i> Keratomileusis and Photorefractive Keratectomy for correction of Myopia and Myopic Astigmatism over One Year Follow-Up.

The open ophthalmology journal·2018
Same journal

Clinical Characteristics, Treatment Outcomes and Predictive Factors in Optic Neuritis.

The open ophthalmology journal·2018
Same journal

A New User-Friendly and Affordable Method in Descemet Stripping Endothelial Keratoplasty.

The open ophthalmology journal·2018
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye
09:03

Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye

Published on: June 20, 2015

Intraocular Pressure: Does it Measure Up?

M Roy Wilson1, Kuldev Singh

  • 1University of Colorado Denver, 1380 Lawrence Street, Suite 1400, Denver, CO 80204, USA.

The Open Ophthalmology Journal
|October 9, 2009
PubMed
Summary
This summary is machine-generated.

The link between intraocular pressure (IOP) and glaucoma is complex. This study questions common assumptions about IOP targets and variability as glaucoma risk factors, comparing IOP

More Related Videos

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

Related Experiment Videos

Last Updated: Jun 19, 2026

Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye
09:03

Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye

Published on: June 20, 2015

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

Area of Science:

  • Ophthalmology
  • Glaucoma research
  • Cardiovascular disease risk assessment

Background:

  • Intraocular pressure (IOP) is widely considered a primary risk factor for glaucoma development and progression.
  • The precise relationship between IOP and glaucoma, including specific target levels and variability, remains incompletely understood.
  • Existing claims regarding IOP control targets and variability as glaucoma risk factors warrant critical evaluation.

Purpose of the Study:

  • To critically assess the validity of several widely accepted claims concerning the relationship between intraocular pressure (IOP) and glaucoma.
  • To investigate the significance of specific IOP targets (e.g., 12 mm Hg) and IOP variability in glaucoma progression.
  • To compare the strength of IOP as a risk factor for glaucoma with that of cardiac risk factors in cardiovascular disease.

Main Methods:

  • Review and analysis of existing claims regarding IOP and glaucoma.
  • Application of treatment effect measures: absolute risk reduction, relative risk, and relative risk reduction.
  • Comparative analysis of IOP's risk factor strength against established cardiovascular risk factors.

Main Results:

  • The study questions the universal validity of claims that 12 mm Hg is a critical IOP target for glaucoma control.
  • The role of IOP variability as a definitive risk factor for glaucoma progression is challenged.
  • The quantitative impact of IOP reduction on glaucoma risk is re-examined, questioning specific percentage-based claims.

Conclusions:

  • The established importance of IOP in glaucoma necessitates a more nuanced understanding beyond simple numerical targets or variability.
  • A comparative analysis suggests that the strength of IOP as a risk factor may be comparable to or even exceed that of certain cardiovascular risk factors.
  • Further research is needed to refine our understanding of IOP's complex role in glaucoma and to establish evidence-based management strategies.